Title:
【発明の名称】シトレアマイシンの新規の使用
Document Type and Number:
Japanese Patent JP2003533474
Kind Code:
A
Abstract:
Citreamicins possess useful antitumor activity. Typically they are of formula, wherein R1 is selected from the group consisting of COCH2CH(CH3)2, COCH3 or H when R2 is CH3, or wherein R1 is COCH2CH(CH3)2, and R2 is H.
More Like This:
| JP2024505252 | Treatment of cancer in patients with PTEN inactivating mutations |
| WO/1992/022552 | IMIDAZO[1,5-a]QUINOXALINES |
| WO/2018/149608 | CRYSTALLINE FORMS OF CABOTEGRAVIR SODIUM |
Inventors:
Jose Luis Fernandez Puentes
Librada Maria Canido Fernandez
Dolores Garcia Gravaros
Julia Perez-Bus
Francisco Romero-Mijan
Fernando Espiego-Vasquez
Librada Maria Canido Fernandez
Dolores Garcia Gravaros
Julia Perez-Bus
Francisco Romero-Mijan
Fernando Espiego-Vasquez
Application Number:
JP2001583751A
Publication Date:
November 11, 2003
Filing Date:
May 17, 2001
Export Citation:
Assignee:
Institute Biomar Societe Anonima
International Classes:
C07D498/14; A61K31/122; A61K31/352; A61K31/42; A61K31/437; A61P35/00; (IPC1-7): A61K31/437; A61P35/00; C07D498/14
Attorney, Agent or Firm:
Masatake Shiga (7 outside)